PLRX
PLRX
US7291391057
Pliant Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
156.373.000 228.365.000
31.5%
Operating Income -156.373.000 -228.365.000
31.5%
Pretax Income -149.344.000 -210.304.000
29.0%
Net Income Common Stockholders -149.344.000 -210.304.000
29.0%
-- --
--
-- --
--
ende